Zydus Cadila launches a fast tracked programme to develop vaccine for the novel coronavirus,...
Zydus Cadila, an innovation-driven, global pharmaceutical company, announced that it has initiated an accelerated research...
Native Antigen Company unveils novel coronavirus antigens
UK-based The Native Antigen Company has commercially introduced novel coronavirus antigens to help fight the...
K T Rama Rao Inaugurates BE’s Plant at Genome Valley & Unveils Typhoid Conjugate...
Mr. K T Rama Rao, Honourable Minister for Information Technology, Industries & Commerce, Municipal Administration...
Benzodiazepine Drugs Market Set to Record US$ 2.6 Bn by 2026; the U.S. to...
The U.S. is expected to account for around one-third of the total share in the...
Regeneron Announces Expanded Collaboration with HHS to Develop Antibody Treatments for New Coronavirus
Regeneron announced an expanded agreement with the U.S. Department of Health and Human Services (HHS)...
Aimmune secures $200m funding from Nestle Health Science
Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing and commercializing treatments for potentially life-threatening...
Grey Wolf completes £2.5m Series A2 financing for development of therapies targeting ERAP2
Grey Wolf Therapeutics, a drug discovery biotechnology company focused on developing first-in-class therapies for immuno-oncology...
New Velesco Pharma clinical manufacturing facility begins operations
Pharmaceutical development expert, Velesco Pharma, is initiating operations at its new state-of-the-art cGMP clinical manufacturing...
Eisai’s DAYVIGO gets approval in Japan to treat insomnia
Eisai Co., Ltd. announced that it has obtained the manufacturing and marketing approval in Japan...
Eisai Commences Joint Research and Development of Cancer Gene Panel Test With Personal Genome...
Eisai Co., Ltd. announced that it has entered into a joint research and development agreement...
